Literature DB >> 25432905

Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary.

Duaa B Saeed1, Limci Gupta1.   

Abstract

We report a case of a 68-year-old woman who presented with symptoms of cerebellar degeneration which initiated a suspicion of underlying malignancy. The patient presented with progressive ataxia and dysarthria and after excluding primary cerebellar pathology, paraneoplastic syndrome was suspected and she was investigated for a malignancy. CT scan of the pelvis showed a left-sided ovarian mass later diagnosed as serous adenocarcinoma of the ovary. She underwent surgery and histology of the mass showed poorly-differentiated serous adenocarcinoma. Paraneoplastic neurological syndrome encompasses several neurological disorders including paraneoplastic cerebellar degeneration (PCD) caused by an immune-mediated mechanism in patients with an underlying malignancy. PCD is a rare condition that occurs in less than 1% of patients with cancer and is associated with specific groups of cancer. It is important to identify PCD due to its association with certain cancers and also to limit the disabilities associated with the syndrome. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25432905      PMCID: PMC4248124          DOI: 10.1136/bcr-2014-206377

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

1.  Paraneoplastic cerebellar degeneration heralding fallopian tube adenocarcinoma.

Authors:  R Levite; A Fishman; A Kesler; M Altaras; N Gadoth
Journal:  Int J Gynecol Cancer       Date:  2001 Mar-Apr       Impact factor: 3.437

2.  Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration.

Authors:  Josef Finsterer; Till Voigtländer; Wolfgang Grisold
Journal:  J Neurol Sci       Date:  2011-07-16       Impact factor: 3.181

3.  Anticerebellar antibodies in serum and cerebrospinal fluid of a patient with oat cell carcinoma of the lung and paraneoplastic cerebellar degeneration.

Authors:  J E Greenlee; H L Lipton
Journal:  Ann Neurol       Date:  1986-01       Impact factor: 10.422

4.  Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies.

Authors:  I Rojas; F Graus; F Keime-Guibert; R Reñé; J Y Delattre; J M Ramón; J Dalmau; J B Posner
Journal:  Neurology       Date:  2000-09-12       Impact factor: 9.910

5.  Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study.

Authors:  I J Jacobs; S Skates; A P Davies; R P Woolas; A Jeyerajah; P Weidemann; K Sibley; D H Oram
Journal:  BMJ       Date:  1996-11-30

6.  Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients.

Authors:  K Peterson; M K Rosenblum; H Kotanides; J B Posner
Journal:  Neurology       Date:  1992-10       Impact factor: 9.910

Review 7.  Managing paraneoplastic neurological disorders.

Authors:  Janet W de Beukelaar; Peter A Sillevis Smitt
Journal:  Oncologist       Date:  2006-03

8.  Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.

Authors:  Setareh Shams'ili; Joost Grefkens; Bertie de Leeuw; Martin van den Bent; Herbert Hooijkaas; Bronno van der Holt; Charles Vecht; Peter Sillevis Smitt
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

9.  Anti-Yo positive paraneoplastic cerebellar degeneration: a report of three cases and review of the literature.

Authors:  T J O'Brien; B Pasaliaris; A D'Apice; E Byrne
Journal:  J Clin Neurosci       Date:  1995-10       Impact factor: 1.961

10.  Paraneoplastic cerebellar degeneration in a woman with ovarian cancer.

Authors:  Antonio Santillan; Robert E Bristow
Journal:  Nat Clin Pract Oncol       Date:  2006-02
View more
  2 in total

Review 1.  Obturator hernias: a systematic review of the literature.

Authors:  D Schizas; K Apostolou; N Hasemaki; P Kanavidis; D Tsapralis; N Garmpis; C Damaskos; A Alexandrou; D Filippou; K Kontzoglou
Journal:  Hernia       Date:  2020-08-09       Impact factor: 4.739

2.  Anti-Yo Mediated Paraneoplastic Cerebellar Degeneration Associated with Pseudobulbar Affect in a Patient with Breast Cancer.

Authors:  Allison N Martin; Patrick M Dillon; David E Jones; David R Brenin; David A Lapides
Journal:  Case Rep Oncol Med       Date:  2017-03-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.